The National Research University "Belgorod State University" is a university in Belgorod, Russia. Belgorod State University is one of the oldest universities in Belgorod and the largest university in the Belgorod region.

During the past decade, Belgorod Regional Oncology Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Belgorod Regional Oncology Center" #1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Belgorod Regional Oncology Center" are "Mantle Cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Belgorod Regional Oncology Center" in a lesser frequency.

Most popular intervention types in "Belgorod Regional Oncology Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib + Rituximab" (1 trials), "Cyclophosphamide 750 mg/m^2" (1 trials), "Doxorubicin 50 mg/m^2" (1 trials), "Prednisone 100 mg/m^2" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Belgorod Regional Oncology Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Belgorod Regional Oncology Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Belgorod Regional Oncology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Belgorod Regional Oncology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".